Boehringer Ingelheim Giotrif

Product Details

Descriptions

For the treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumours have activating epidermal growth factor receptor (EGFR) mutations. For the treatment of patients with locally advanced or metastatic NSCLC of squamous histology progressing on or after platinum based chemotherapy.

Get Reviews Widget

Leave a review

You may also like...

İstanbul escort mersin escort kocaeli escort sakarya escort antalya Escort adana Escort escort bayan escort mersin

elazığ Escort escort ankara escort bayan izmir escort adana escort antalya escort bursa konya escort bayan hatay escort bayan